-
National MS Society Objects to $88,000 List Price of Vumerity
The National MS Society has criticized Biogen for the $88,000 yearly list price it placed on Vumerity, and for repeated price increases with Tecfidera. Learn more here.
Do you agree with the criticism Biogren is receiving about their pricing? What do you want them to know from your perspective as a patient or caregiver?
Sorry, there were no replies found.
Log in to reply.